IL-22 Preserves Gut Epithelial Integrity and Promotes Disease Remission during Chronic Salmonella Infection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-22 Preserves Gut Epithelial Integrity and Promotes Disease Remission during Chronic Salmonella Infection
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 202, Issue 3, Pages 956-965
Publisher
The American Association of Immunologists
Online
2019-01-08
DOI
10.4049/jimmunol.1801308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection
- (2018) Amanda Jacobson et al. Cell Host & Microbe
- Emerging concepts and future challenges in innate lymphoid cell biology
- (2016) Elia D. Tait Wojno et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
- (2016) David R Withers et al. NATURE MEDICINE
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
- (2015) Joseph R. Maxwell et al. IMMUNITY
- Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage
- (2015) Patricia Aparicio-Domingo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
- (2015) Caroline A. Lindemans et al. NATURE
- Epithelial IL-22RA1-Mediated Fucosylation Promotes Intestinal Colonization Resistance to an Opportunistic Pathogen
- (2014) Tu Anh N. Pham et al. Cell Host & Microbe
- The Cytokine IL-22 Promotes Pathogen Colonization by Suppressing Related Commensal Bacteria
- (2014) Judith Behnsen et al. IMMUNITY
- CX3CR1+mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
- (2014) Randy S. Longman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness
- (2014) Joseph M. Pickard et al. NATURE
- Innate lymphoid cells regulate intestinal epithelial cell glycosylation
- (2014) Y. Goto et al. SCIENCE
- EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9 and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
- (2013) William A Faubion et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
- (2013) James J. Kozich et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Crohn's disease complicated by strictures: a systematic review
- (2013) Florian Rieder et al. GUT
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
- (2013) Stefanie Kirchberger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
- (2013) A Eken et al. Mucosal Immunology
- Stabilization of cooperative virulence by the expression of an avirulent phenotype
- (2013) Médéric Diard et al. NATURE
- Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
- (2013) Jochem H Bernink et al. NATURE IMMUNOLOGY
- Therapeutic opportunities of the IL-22–IL-22R1 system
- (2013) Robert Sabat et al. NATURE REVIEWS DRUG DISCOVERY
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
- (2013) Paul J. McMurdie et al. PLoS One
- MyD88 signaling promotes both mucosal homeostatic and fibrotic responses during Salmonella-induced colitis
- (2012) Lisa E. Månsson et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
- (2012) Alan M. Hanash et al. IMMUNITY
- Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease
- (2012) Anders Dige et al. Journal of Crohns & Colitis
- Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria
- (2012) G. F. Sonnenberg et al. SCIENCE
- Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: Impact of a “Top-Down” approach to intestinal fibrosis in mice
- (2011) Laura A. Johnson et al. INFLAMMATORY BOWEL DISEASES
- The Antibacterial Lectin RegIII Promotes the Spatial Segregation of Microbiota and Host in the Intestine
- (2011) S. Vaishnava et al. SCIENCE
- The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Salmonella Diarrhea
- (2010) Kathrin Endt et al. PLoS Pathogens
- Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
- (2009) P. D. Schloss et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- Chronic Enteric Salmonella Infection in Mice Leads to Severe and Persistent Intestinal Fibrosis
- (2008) Guntram A. Grassl et al. GASTROENTEROLOGY
- T Cells Help To Amplify Inflammatory Responses Induced by Salmonella enterica Serotype Typhimurium in the Intestinal Mucosa
- (2008) I. Godinez et al. INFECTION AND IMMUNITY
- IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
- (2008) Shean J Aujla et al. NATURE MEDICINE
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
- (2008) Yan Zheng et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started